Search clinical trials for: doxorubicin intravenous

Total 8192 results

French Innovative Leukemia Organisation

Completed

Liposomal Anthracyclin in the Treatment of Elderly ALL

Acute Lymphoblastic Leukemia

France
SOLTI Breast Cancer Research Group
Schering-Plough

Completed

Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years (CAPRICE)

Breast Cancer

Spain
Tularik

Terminated

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma

United States, Russian Federation, United Kingdom, Singapore, Thailand, Ukraine, Brazil, China, Poland, Puerto Rico, South Africa
Yale University

Completed

Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer

Liver Cancer

United States
Jia Fan

Unknown

TACE as an Adjuvant Therapy After Hepatectomy for HCC

Hepatocellular Carcinoma

China
National Cancer Institute, Naples

Completed

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Endometrial Cancer

Italy
M.D. Anderson Cancer Center

Completed

Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement

Advanced Cancer

United States
Eli Lilly and Company

Completed

Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors

Solid Tumors

United States
Bayer

Completed

A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong, Canada, Russian Federation, United States, Argentina, United Kingdom
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Metastatic Cancer | Liver Cancer

United States, China
University of Glasgow

Unknown

Doxorubicin in Treating Women With Advanced Breast Cancer

Breast Cancer

United Kingdom
Sanofi

Completed

BIG 02/98 Docetaxel - Breast Cancer

Breast Neoplasms

Spain, Italy, Australia, Czech Republic, Germany, Hungary, Ireland, Israel, New Zealand, Portugal, Slovenia, Slovakia, Austria, Sweden, United Kingdom, Belgium, Brazil, Chile, Denmark, South Africa, Switzerland
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer

Ovarian Cancer Metastatic Recurrent

Italy
University of Regensburg
Essex Pharma Germany

Completed

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma

Germany
Theodore Laetsch

Withdrawn

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

Sarcoma | Osteosarcoma | Sarcoma, Ewing | Neuroblastoma | Rhabdomyosarcoma | Desmoid

United States
University of Wisconsin, Madison
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.

Terminated

Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Alaunos Therapeutics

Unknown

A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma (PICASSO)

Soft Tissue Sarcoma

United States, Italy, Romania
University of Southern California
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)

Carcinoma | Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Breast Cancer

United States
Lahey Clinic
Varian Medical Systems

Completed

Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant (SBRTvsTACE)

HCC | Hepatocellular Carcinoma

United States
Grupo Oncológico Gallego
Pivotal S.L.

Unknown

Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer

Breast Cancer

Spain
Lahey Clinic
Varian Medical Systems; Merit Medical Systems, Inc.

Active, not recruiting

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant (SBRTvsTACE)

HCC | Hepatocellular Carcinoma

United States, Canada
SCRI Development Innovations, LLC
GlaxoSmithKline

Terminated

Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Aventis Pharmaceuticals

Completed

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Breast Cancer

United States
Peking Union Medical College Hospital

Unknown

AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer

Breast Cancer

China
Mansoura University

Active, not recruiting

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Breast Cancer Female

Egypt
Peking Union Medical College Hospital

Completed

DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer

Breast Cancer
Women and Infants Hospital of Rhode Island
Ortho Biotech, Inc.

Terminated

Doxil and Gemcitabine in Recurrent Ovarian Cancer

Ovarian Carcinoma

United States
Celgene Corporation
Prologue Research International

Terminated

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Wyeth is now a wholly owned subsidiary of Pfizer; National Comprehensive Cancer...

Completed

Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma

Sarcoma

United States
Gem Pharmaceuticals

Completed

Safety Study of GPX-150 in Patients With Solid Tumors

Advanced Solid Tumors - Phase 1 Population

United States
The Netherlands Cancer Institute
Bristol-Myers Squibb

Recruiting

Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients (TONIC-2)

Metastatic Breast Cancer

Netherlands
National Cancer Institute (NCI)

Completed

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

Sarcoma, Kaposi

United States
Masonic Cancer Center, University of Minnesota
Celgene Corporation

Terminated

Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Mansoura University

Active, not recruiting

Effect of Pentoxifylline on Preventing Chemotherapy-induced Mucositis in Patients With Breast Cancer

Breast Cancer Female

Egypt
Peking University International Hospital
Peking University First Hospital; Beijing Friendship Hospital; Shanghai Zhongshan... and other collaborators

Enrolling by invitation

Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma (NATARS)

Retroperitoneal Sarcoma

China
OHSU Knight Cancer Institute
Novartis Pharmaceuticals; Oregon Health and Science University

Completed

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Locally Advanced Leiomyosarcoma | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Unresectable... and other conditions

United States
University Health Network, Toronto

Recruiting

In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma

Soft Tissue Sarcoma | Pulmonary Metastases | Bone Sarcoma

Canada
National University Hospital, Singapore

Unknown

Correlation Between Genetic Variants and Long-term Cardiac Effects Induced by Doxorubicin in Breast Cancer Patients

Breast Cancer

Singapore
Meir Medical Center

Completed

Doxorubicin Pharmacokinetics and Response in Non Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Israel
Tesaro, Inc.

Terminated

A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)

Cancer: Solid Tumors
German Breast Group

Completed

German Preoperative Adriamycin Docetaxel Study

Breast Neoplasms
Institut Claudius Regaud

Completed

Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma (IPIAP-STM)

Soft Tissue Sarcoma

France
University Health Network, Toronto
Karyopharm Therapeutics Inc

Completed

Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas

Soft Tissue Sarcoma

Canada
Spanish Breast Cancer Research Group
Sanofi; Hoffmann-La Roche; Amgen; Cephalon

Completed

Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients

Breast Cancer

Spain
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Breast Cancer

United States, Canada, Peru
Seoul National University Hospital

Completed

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy (DA-PET)

Breast Cancer
Guangxi Medical University

Withdrawn

Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma (LD-FOX4/HCC)

Hepatocellular Carcinoma
Azaya Therapeutics, Inc.

Unknown

A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

Cancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian Tumor

Canada, United States
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Unresectable Hepatocellular Carcinoma | Advanced Adult Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | Stage IIIB Hepatocellular Carcinoma AJCC v7 | Stage IIIC Hepatocellular Carcinoma AJCC v7 | Stage IV Hepatocellular Carcinoma AJCC v7 | Stage III Hepatocellular Carcinoma AJCC v7 and other conditions

United States, Canada, Puerto Rico

Search clinical trials for: doxorubicin intravenous

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations